Delivery Order SPE2DB24D1205-SPE2DB25FCZCZ
- Not listed
- The Defense Logistics Agency awarded a $17,006.14 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract. The award was issued on July 30, 2025, with a completion date of July 31, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $3,484.49. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026. The delivery order carries an ultimate completion date of July...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $12,471.65 for supply of Eliquis 5 mg tablets (60-count units). This competitive, non-set-aside award utilizes firm fixed pricing and is scheduled for completion by July 29, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count supply) on July 21, 2025, with completion targeted for July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects standard pharmaceutical procurement through the federal medical supply chain. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,747.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply needs, particularly supporting...
- The Defense Logistics Agency awarded a $17,736.14 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $25,897.33. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,924.38 on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and calls for ultimate completion by July 21, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) valued at $21,325.65 under a firm fixed-price contract. This non-set-aside award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order falls under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $9,414.24. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and represents fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical supply vehicle running through December 2026. The place of...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZCZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract valued at $2,047.50. The order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive procurement with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $1 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. As the prime contractor on the DLA Troop Support Medical IDC, the company supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its comprehensive pharmaceutical supply network, positions it to support the Defense Logistics Agency's medical supply chain for military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/31/25 |